Related Experiment Video
Updated: May 18, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Physiologically based pharmacokinetic modeling for nanoparticle toxicity study.
1Optimum Therapeutics, LLC, San Diego, CA, USA.
Physiologically based pharmacokinetic (PBPK) models are being adapted for nanoparticle toxicity studies. These models predict how nanoparticles distribute in the body, aiding in toxicity assessments.
Area of Science:
- Pharmacokinetics and Toxicology
- Nanomaterial Science
- Computational Biology
Background:
- Physiologically Based Pharmacokinetic (PBPK) models are established tools in pharmacology and toxicology for small molecules.
- Current applications of PBPK models for nanoparticles are in nascent stages.
- Nanoparticles exhibit distinct biodistribution characteristics compared to small molecules, necessitating model adaptations.
Purpose of the Study:
- To introduce the principles and development procedures for PBPK models tailored for nanoparticle toxicity.
- To explore the potential applications of PBPK models in nanoparticle risk assessment.
Main Methods:
- Discussion of PBPK model development principles.
- Exploration of modifications required for nanoparticle PBPK models.
- Review of PBPK model applications in nanoparticle biodistribution and toxicity.
Main Results:
- PBPK models describe chemical or nanoparticle concentration-time profiles within body tissues and organs.
- Adaptations to PBPK models are crucial due to differences in nanoparticle biodistribution.
- Potential applications include biodistribution prediction, data extrapolation, and establishing property-biodistribution relationships.
Conclusions:
- PBPK models offer a powerful framework for evaluating nanoparticle toxicity.
- Further development of nanoparticle PBPK models is essential for advancing safety assessments.
- These models can significantly enhance our understanding of nanoparticle behavior in biological systems.
More Related Videos
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

